SALVATORELLI, EMANUELA

SALVATORELLI, EMANUELA  

Facoltà Dipartimentale di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 80 (tempo di esecuzione: 0.078 secondi).
Titolo Data di pubblicazione Autore(i) File
4’- Epidoxorubicin to reexplore anthracycline degradation in cardiomyocytes 1-gen-2009 Menna, P; Salvatorelli, E; Minotti, G
Anthracycline Cardiotoxicity 1-gen-2008 Menna, P.; Salvatorelli, E.; Gianni, L.; Minotti, G
Anthracycline Cardiotoxicity 1-gen-2012 Menna, P; Gonzalez Paz, O; Chello, M; Covino, E; Salvatorelli, E; Minotti, G
Anthracycline cardiotoxicity in breast cancer patients: Synergism with trastuzumab and taxanes 1-gen-2007 Gianni, L; Salvatorelli, E; Minotti, G
Anthracycline degradation in cardiomyocytes: a journey to oxidative survival 1-gen-2010 Menna, P; Salvatorelli, E; Minotti, G
Anthracyclines 1-gen-2008 Minotti, G; Salvatorelli, E; Menna, P
Anthracyclines and Cardiotoxicity: Is CARP a Forgotten Biomarker? 1-gen-2023 Minotti, Giorgio; Salvatorelli, Emanuela; Menna, Pierantonio
Anthracyclines: molecular advances and pharmacological developments in antitumor activity and cardiotoxicity 1-gen-2004 Minotti, G; Menna, P; Salvatorelli, E; Cairo, G; Gianni, L.
Beyond hypertension: Diastolic dysfunction associated with cancer treatment in the era of cardio-oncology 1-gen-2022 Minotti, Giorgio; Menna, Pierantonio; Camilli, Massimiliano; Salvatorelli, Emanuela; Levi, Roberto
Cancer drugs and QT prolongation: weighing risk against benefit 1-gen-2017 Menna, P.; Salvatorelli, E; Minotti, G.
CARDIAC ANTHRACYCLINE ACCUMULATION AND B-TYPE NATRIURETIC PEPTIDE TO DEFINE RISK AND PREDICTORS OF CANCER TREATMENT RELATED EARLY DIASTOLIC DYSFUNCTION 1-gen-2022 Minotti, Giorgio; Salvatorelli, Emanuela; Reggiardo, Giorgio; Mangiacapra, Fabio; Camilli, Massimiliano; Menna, Pierantonio
Cardiotoxicity of antitumor drugs 1-gen-2008 Menna, P; Salvatorelli, E; Minotti, G
Cardiotoxicity of targeted cancer drugs: concerns, “The cart before the horse,” and lessons from trastuzumab 1-gen-2019 Menna, P; Minotti, G; Salvatorelli, E.
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 1-gen-2011 Cacciapaglia F, F.; Navarini, L.; Menna, P.; Salvatorelli, E.; Minotti, G; Afeltra, A.
Cardiovascular toxicity of antitumor drugs :Translating molecular mechanisms into clinical facts 1-gen-2010 Menna, P.; Salvatorelli, E.; Salsano, C.; Gianni, L.; Minotti, G.
Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life 1-gen-2021 Menna, P; Salvatorelli, E; Del Principe, Mi; Perrone, S; Pagano, L; Marchesi, F; Minotti, G.
Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity 1-gen-2003 Sacco, G.; Giampietro, R.; Salvatorelli, E.; Menna, P; Bertani, N.; Graiani, G.; Animati, F.; Goso, C.; Maggi, C. A.; Mancinis, S.; Minotti, G.
Defective one or two electron reduction of the anticancer anthracycline epirubicin in human heart: Relative importance of vesicular sequestration and impaired efficiency of electron addition 1-gen-2006 Salvatorelli, E; Guarnieri, S; Menna, P; Liberi, G; Calafiore, Am; Mariggio, Ma; Mordente, A; Gianni, L; Minotti, G
Defective taxane stimulation of epirubicinol formation in the human heart: Insights into the cardiac tolerability of epirubicin-taxane chemotherapies 1-gen-2007 Salvatorelli, E.; Menna, P.; Gianni, L.; Minotti, G
Do you know pixantrone? 1-gen-2017 Minotti, G.; Menna, P.; Salvatorelli, E